Trials / Completed
CompletedNCT06117007
Effects of Betalains on Cardiovascular Health and Quality of Life
A Randomised, Placebo-controlled, Crossover Study of the Effects of a Betalain-rich Extract on Vascular Function, Sleep and Quality of Life in Middle-Aged Individuals
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- King's College London · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The goal of this randomized, double-blind, placebo-controlled, cross-over trial is to investigate the effects of beetroot-derived betalains on cardiovascular health, sleep and quality of life in healthy middle-aged individuals. The main question\[s\] it aims to answer are: * Do betalains improve vascular function? * Do betalains improve sleep? * Do betalains improve quality of life? Participants will be involved with the following: * Consuming a daily betalain-rich or placebo capsule for a month * Non-invasive cardiovascular measurements * Wearing a fitness tracker for tracking physical activity and sleep * Answering questionnaires regarding quality of life Researchers will compare results between the intervention versus the placebo group to see if any of the study outcomes are significantly different.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Betalains | Betalains extracted from red beetroot (Beta vulgaris) encapsulated in edible capsules. (25 mg betalains per capsule) |
| OTHER | Placebo | Placebo capsules containing rice hulls. (0 mg betalains per capsule) |
Timeline
- Start date
- 2023-10-30
- Primary completion
- 2024-12-19
- Completion
- 2024-12-19
- First posted
- 2023-11-03
- Last updated
- 2025-11-14
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06117007. Inclusion in this directory is not an endorsement.